Markus Richard bought RCUS

February 10, 2025 · Form 4 insider transaction

Markus Richard bought 305,328 shares of Arcus Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
305,328
Price
$0.00
Total value
N/A
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 10, 2025
Filing dateFebruary 11, 2025
Shares owned after305,328
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option becomes exercisable in 48 equal monthly installments after February 1, 2025, subject to the Reporting Person's continued service to the Company

View the original Form 4 on SEC EDGAR